Global Bio-based Hemostatic Powder Market Growth 2026-2032
The global Bio-based Hemostatic Powder market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Bio-based hemostatic powder is a hemostatic product made from natural biomaterials, designed to quickly control bleeding and promote wound healing. It is usually made of biomaterials such as plant extracts, chitosan, collagen, etc., and has good biocompatibility and degradability. Its working mechanism is to quickly stop bleeding by adsorbing blood, promoting platelet aggregation and accelerating blood clot formation. Bio-based hemostatic powder is widely used in trauma emergency treatment, surgery and other medical scenarios because its natural ingredients are friendly to the human body and can effectively reduce the risk of infection and complications.
United States market for Bio-based Hemostatic Powder is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Bio-based Hemostatic Powder is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Bio-based Hemostatic Powder is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Bio-based Hemostatic Powder players cover Johnson & Johnson, Medtronic, Baxter, BioCer Entwicklungs-GmbH, BD, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Bio-based Hemostatic Powder Industry Forecast” looks at past sales and reviews total world Bio-based Hemostatic Powder sales in 2025, providing a comprehensive analysis by region and market sector of projected Bio-based Hemostatic Powder sales for 2026 through 2032. With Bio-based Hemostatic Powder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bio-based Hemostatic Powder industry.
This Insight Report provides a comprehensive analysis of the global Bio-based Hemostatic Powder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bio-based Hemostatic Powder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bio-based Hemostatic Powder market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bio-based Hemostatic Powder and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bio-based Hemostatic Powder.
This report presents a comprehensive overview, market shares, and growth opportunities of Bio-based Hemostatic Powder market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Bio-based Hemostatic Powder market?
What factors are driving Bio-based Hemostatic Powder market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bio-based Hemostatic Powder market opportunities vary by end market size?
How does Bio-based Hemostatic Powder break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
Bio-based hemostatic powder is a hemostatic product made from natural biomaterials, designed to quickly control bleeding and promote wound healing. It is usually made of biomaterials such as plant extracts, chitosan, collagen, etc., and has good biocompatibility and degradability. Its working mechanism is to quickly stop bleeding by adsorbing blood, promoting platelet aggregation and accelerating blood clot formation. Bio-based hemostatic powder is widely used in trauma emergency treatment, surgery and other medical scenarios because its natural ingredients are friendly to the human body and can effectively reduce the risk of infection and complications.
United States market for Bio-based Hemostatic Powder is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Bio-based Hemostatic Powder is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Bio-based Hemostatic Powder is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Bio-based Hemostatic Powder players cover Johnson & Johnson, Medtronic, Baxter, BioCer Entwicklungs-GmbH, BD, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Bio-based Hemostatic Powder Industry Forecast” looks at past sales and reviews total world Bio-based Hemostatic Powder sales in 2025, providing a comprehensive analysis by region and market sector of projected Bio-based Hemostatic Powder sales for 2026 through 2032. With Bio-based Hemostatic Powder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bio-based Hemostatic Powder industry.
This Insight Report provides a comprehensive analysis of the global Bio-based Hemostatic Powder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bio-based Hemostatic Powder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bio-based Hemostatic Powder market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bio-based Hemostatic Powder and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bio-based Hemostatic Powder.
This report presents a comprehensive overview, market shares, and growth opportunities of Bio-based Hemostatic Powder market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Oxidized Cellulose
- Polysaccharides
- Other
- Surgery
- First Aid
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Johnson & Johnson
- Medtronic
- Baxter
- BioCer Entwicklungs-GmbH
- BD
- Hemostasis
- MedTrade Products
- Lanhine Medical
- Haiyuan Hairun
- Yancheng Yankang Medical Equipment
- Success Bio-Tech
- Beijing Aitekang Medical Technology
What is the 10-year outlook for the global Bio-based Hemostatic Powder market?
What factors are driving Bio-based Hemostatic Powder market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bio-based Hemostatic Powder market opportunities vary by end market size?
How does Bio-based Hemostatic Powder break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bio-based Hemostatic Powder Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Bio-based Hemostatic Powder by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Bio-based Hemostatic Powder by Country/Region, 2021, 2025 & 2032
2.2 Bio-based Hemostatic Powder Segment by Type
2.2.1 Oxidized Cellulose
2.2.2 Polysaccharides
2.2.3 Other
2.2.4 Bio-based Hemostatic Powder Sales by Type
2.2.4.1 Global Bio-based Hemostatic Powder Sales Market Share by Type (2021-2026)
2.2.4.2 Global Bio-based Hemostatic Powder Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Bio-based Hemostatic Powder Sale Price by Type (2021-2026)
2.3 Bio-based Hemostatic Powder Segment by Application
2.3.1 Surgery
2.3.2 First Aid
2.3.3 Bio-based Hemostatic Powder Sales by Application
2.3.3.1 Global Bio-based Hemostatic Powder Sale Market Share by Application (2021-2026)
2.3.3.2 Global Bio-based Hemostatic Powder Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Bio-based Hemostatic Powder Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Bio-based Hemostatic Powder Breakdown Data by Company
3.1.1 Global Bio-based Hemostatic Powder Annual Sales by Company (2021-2026)
3.1.2 Global Bio-based Hemostatic Powder Sales Market Share by Company (2021-2026)
3.2 Global Bio-based Hemostatic Powder Annual Revenue by Company (2021-2026)
3.2.1 Global Bio-based Hemostatic Powder Revenue by Company (2021-2026)
3.2.2 Global Bio-based Hemostatic Powder Revenue Market Share by Company (2021-2026)
3.3 Global Bio-based Hemostatic Powder Sale Price by Company
3.4 Key Manufacturers Bio-based Hemostatic Powder Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bio-based Hemostatic Powder Product Location Distribution
3.4.2 Players Bio-based Hemostatic Powder Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BIO-BASED HEMOSTATIC POWDER BY GEOGRAPHIC REGION
4.1 World Historic Bio-based Hemostatic Powder Market Size by Geographic Region (2021-2026)
4.1.1 Global Bio-based Hemostatic Powder Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Bio-based Hemostatic Powder Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Bio-based Hemostatic Powder Market Size by Country/Region (2021-2026)
4.2.1 Global Bio-based Hemostatic Powder Annual Sales by Country/Region (2021-2026)
4.2.2 Global Bio-based Hemostatic Powder Annual Revenue by Country/Region (2021-2026)
4.3 Americas Bio-based Hemostatic Powder Sales Growth
4.4 APAC Bio-based Hemostatic Powder Sales Growth
4.5 Europe Bio-based Hemostatic Powder Sales Growth
4.6 Middle East & Africa Bio-based Hemostatic Powder Sales Growth
5 AMERICAS
5.1 Americas Bio-based Hemostatic Powder Sales by Country
5.1.1 Americas Bio-based Hemostatic Powder Sales by Country (2021-2026)
5.1.2 Americas Bio-based Hemostatic Powder Revenue by Country (2021-2026)
5.2 Americas Bio-based Hemostatic Powder Sales by Type (2021-2026)
5.3 Americas Bio-based Hemostatic Powder Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bio-based Hemostatic Powder Sales by Region
6.1.1 APAC Bio-based Hemostatic Powder Sales by Region (2021-2026)
6.1.2 APAC Bio-based Hemostatic Powder Revenue by Region (2021-2026)
6.2 APAC Bio-based Hemostatic Powder Sales by Type (2021-2026)
6.3 APAC Bio-based Hemostatic Powder Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Bio-based Hemostatic Powder by Country
7.1.1 Europe Bio-based Hemostatic Powder Sales by Country (2021-2026)
7.1.2 Europe Bio-based Hemostatic Powder Revenue by Country (2021-2026)
7.2 Europe Bio-based Hemostatic Powder Sales by Type (2021-2026)
7.3 Europe Bio-based Hemostatic Powder Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bio-based Hemostatic Powder by Country
8.1.1 Middle East & Africa Bio-based Hemostatic Powder Sales by Country (2021-2026)
8.1.2 Middle East & Africa Bio-based Hemostatic Powder Revenue by Country (2021-2026)
8.2 Middle East & Africa Bio-based Hemostatic Powder Sales by Type (2021-2026)
8.3 Middle East & Africa Bio-based Hemostatic Powder Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bio-based Hemostatic Powder
10.3 Manufacturing Process Analysis of Bio-based Hemostatic Powder
10.4 Industry Chain Structure of Bio-based Hemostatic Powder
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bio-based Hemostatic Powder Distributors
11.3 Bio-based Hemostatic Powder Customer
12 WORLD FORECAST REVIEW FOR BIO-BASED HEMOSTATIC POWDER BY GEOGRAPHIC REGION
12.1 Global Bio-based Hemostatic Powder Market Size Forecast by Region
12.1.1 Global Bio-based Hemostatic Powder Forecast by Region (2027-2032)
12.1.2 Global Bio-based Hemostatic Powder Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Bio-based Hemostatic Powder Forecast by Type (2027-2032)
12.7 Global Bio-based Hemostatic Powder Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Bio-based Hemostatic Powder Product Portfolios and Specifications
13.1.3 Johnson & Johnson Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Bio-based Hemostatic Powder Product Portfolios and Specifications
13.2.3 Medtronic Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Baxter
13.3.1 Baxter Company Information
13.3.2 Baxter Bio-based Hemostatic Powder Product Portfolios and Specifications
13.3.3 Baxter Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Baxter Main Business Overview
13.3.5 Baxter Latest Developments
13.4 BioCer Entwicklungs-GmbH
13.4.1 BioCer Entwicklungs-GmbH Company Information
13.4.2 BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Product Portfolios and Specifications
13.4.3 BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 BioCer Entwicklungs-GmbH Main Business Overview
13.4.5 BioCer Entwicklungs-GmbH Latest Developments
13.5 BD
13.5.1 BD Company Information
13.5.2 BD Bio-based Hemostatic Powder Product Portfolios and Specifications
13.5.3 BD Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 BD Main Business Overview
13.5.5 BD Latest Developments
13.6 Hemostasis
13.6.1 Hemostasis Company Information
13.6.2 Hemostasis Bio-based Hemostatic Powder Product Portfolios and Specifications
13.6.3 Hemostasis Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Hemostasis Main Business Overview
13.6.5 Hemostasis Latest Developments
13.7 MedTrade Products
13.7.1 MedTrade Products Company Information
13.7.2 MedTrade Products Bio-based Hemostatic Powder Product Portfolios and Specifications
13.7.3 MedTrade Products Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 MedTrade Products Main Business Overview
13.7.5 MedTrade Products Latest Developments
13.8 Lanhine Medical
13.8.1 Lanhine Medical Company Information
13.8.2 Lanhine Medical Bio-based Hemostatic Powder Product Portfolios and Specifications
13.8.3 Lanhine Medical Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Lanhine Medical Main Business Overview
13.8.5 Lanhine Medical Latest Developments
13.9 Haiyuan Hairun
13.9.1 Haiyuan Hairun Company Information
13.9.2 Haiyuan Hairun Bio-based Hemostatic Powder Product Portfolios and Specifications
13.9.3 Haiyuan Hairun Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Haiyuan Hairun Main Business Overview
13.9.5 Haiyuan Hairun Latest Developments
13.10 Yancheng Yankang Medical Equipment
13.10.1 Yancheng Yankang Medical Equipment Company Information
13.10.2 Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Product Portfolios and Specifications
13.10.3 Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Yancheng Yankang Medical Equipment Main Business Overview
13.10.5 Yancheng Yankang Medical Equipment Latest Developments
13.11 Success Bio-Tech
13.11.1 Success Bio-Tech Company Information
13.11.2 Success Bio-Tech Bio-based Hemostatic Powder Product Portfolios and Specifications
13.11.3 Success Bio-Tech Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Success Bio-Tech Main Business Overview
13.11.5 Success Bio-Tech Latest Developments
13.12 Beijing Aitekang Medical Technology
13.12.1 Beijing Aitekang Medical Technology Company Information
13.12.2 Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Product Portfolios and Specifications
13.12.3 Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Beijing Aitekang Medical Technology Main Business Overview
13.12.5 Beijing Aitekang Medical Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bio-based Hemostatic Powder Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Bio-based Hemostatic Powder by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Bio-based Hemostatic Powder by Country/Region, 2021, 2025 & 2032
2.2 Bio-based Hemostatic Powder Segment by Type
2.2.1 Oxidized Cellulose
2.2.2 Polysaccharides
2.2.3 Other
2.2.4 Bio-based Hemostatic Powder Sales by Type
2.2.4.1 Global Bio-based Hemostatic Powder Sales Market Share by Type (2021-2026)
2.2.4.2 Global Bio-based Hemostatic Powder Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Bio-based Hemostatic Powder Sale Price by Type (2021-2026)
2.3 Bio-based Hemostatic Powder Segment by Application
2.3.1 Surgery
2.3.2 First Aid
2.3.3 Bio-based Hemostatic Powder Sales by Application
2.3.3.1 Global Bio-based Hemostatic Powder Sale Market Share by Application (2021-2026)
2.3.3.2 Global Bio-based Hemostatic Powder Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Bio-based Hemostatic Powder Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Bio-based Hemostatic Powder Breakdown Data by Company
3.1.1 Global Bio-based Hemostatic Powder Annual Sales by Company (2021-2026)
3.1.2 Global Bio-based Hemostatic Powder Sales Market Share by Company (2021-2026)
3.2 Global Bio-based Hemostatic Powder Annual Revenue by Company (2021-2026)
3.2.1 Global Bio-based Hemostatic Powder Revenue by Company (2021-2026)
3.2.2 Global Bio-based Hemostatic Powder Revenue Market Share by Company (2021-2026)
3.3 Global Bio-based Hemostatic Powder Sale Price by Company
3.4 Key Manufacturers Bio-based Hemostatic Powder Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bio-based Hemostatic Powder Product Location Distribution
3.4.2 Players Bio-based Hemostatic Powder Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BIO-BASED HEMOSTATIC POWDER BY GEOGRAPHIC REGION
4.1 World Historic Bio-based Hemostatic Powder Market Size by Geographic Region (2021-2026)
4.1.1 Global Bio-based Hemostatic Powder Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Bio-based Hemostatic Powder Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Bio-based Hemostatic Powder Market Size by Country/Region (2021-2026)
4.2.1 Global Bio-based Hemostatic Powder Annual Sales by Country/Region (2021-2026)
4.2.2 Global Bio-based Hemostatic Powder Annual Revenue by Country/Region (2021-2026)
4.3 Americas Bio-based Hemostatic Powder Sales Growth
4.4 APAC Bio-based Hemostatic Powder Sales Growth
4.5 Europe Bio-based Hemostatic Powder Sales Growth
4.6 Middle East & Africa Bio-based Hemostatic Powder Sales Growth
5 AMERICAS
5.1 Americas Bio-based Hemostatic Powder Sales by Country
5.1.1 Americas Bio-based Hemostatic Powder Sales by Country (2021-2026)
5.1.2 Americas Bio-based Hemostatic Powder Revenue by Country (2021-2026)
5.2 Americas Bio-based Hemostatic Powder Sales by Type (2021-2026)
5.3 Americas Bio-based Hemostatic Powder Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bio-based Hemostatic Powder Sales by Region
6.1.1 APAC Bio-based Hemostatic Powder Sales by Region (2021-2026)
6.1.2 APAC Bio-based Hemostatic Powder Revenue by Region (2021-2026)
6.2 APAC Bio-based Hemostatic Powder Sales by Type (2021-2026)
6.3 APAC Bio-based Hemostatic Powder Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Bio-based Hemostatic Powder by Country
7.1.1 Europe Bio-based Hemostatic Powder Sales by Country (2021-2026)
7.1.2 Europe Bio-based Hemostatic Powder Revenue by Country (2021-2026)
7.2 Europe Bio-based Hemostatic Powder Sales by Type (2021-2026)
7.3 Europe Bio-based Hemostatic Powder Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bio-based Hemostatic Powder by Country
8.1.1 Middle East & Africa Bio-based Hemostatic Powder Sales by Country (2021-2026)
8.1.2 Middle East & Africa Bio-based Hemostatic Powder Revenue by Country (2021-2026)
8.2 Middle East & Africa Bio-based Hemostatic Powder Sales by Type (2021-2026)
8.3 Middle East & Africa Bio-based Hemostatic Powder Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bio-based Hemostatic Powder
10.3 Manufacturing Process Analysis of Bio-based Hemostatic Powder
10.4 Industry Chain Structure of Bio-based Hemostatic Powder
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bio-based Hemostatic Powder Distributors
11.3 Bio-based Hemostatic Powder Customer
12 WORLD FORECAST REVIEW FOR BIO-BASED HEMOSTATIC POWDER BY GEOGRAPHIC REGION
12.1 Global Bio-based Hemostatic Powder Market Size Forecast by Region
12.1.1 Global Bio-based Hemostatic Powder Forecast by Region (2027-2032)
12.1.2 Global Bio-based Hemostatic Powder Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Bio-based Hemostatic Powder Forecast by Type (2027-2032)
12.7 Global Bio-based Hemostatic Powder Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Bio-based Hemostatic Powder Product Portfolios and Specifications
13.1.3 Johnson & Johnson Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Bio-based Hemostatic Powder Product Portfolios and Specifications
13.2.3 Medtronic Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Baxter
13.3.1 Baxter Company Information
13.3.2 Baxter Bio-based Hemostatic Powder Product Portfolios and Specifications
13.3.3 Baxter Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Baxter Main Business Overview
13.3.5 Baxter Latest Developments
13.4 BioCer Entwicklungs-GmbH
13.4.1 BioCer Entwicklungs-GmbH Company Information
13.4.2 BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Product Portfolios and Specifications
13.4.3 BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 BioCer Entwicklungs-GmbH Main Business Overview
13.4.5 BioCer Entwicklungs-GmbH Latest Developments
13.5 BD
13.5.1 BD Company Information
13.5.2 BD Bio-based Hemostatic Powder Product Portfolios and Specifications
13.5.3 BD Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 BD Main Business Overview
13.5.5 BD Latest Developments
13.6 Hemostasis
13.6.1 Hemostasis Company Information
13.6.2 Hemostasis Bio-based Hemostatic Powder Product Portfolios and Specifications
13.6.3 Hemostasis Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Hemostasis Main Business Overview
13.6.5 Hemostasis Latest Developments
13.7 MedTrade Products
13.7.1 MedTrade Products Company Information
13.7.2 MedTrade Products Bio-based Hemostatic Powder Product Portfolios and Specifications
13.7.3 MedTrade Products Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 MedTrade Products Main Business Overview
13.7.5 MedTrade Products Latest Developments
13.8 Lanhine Medical
13.8.1 Lanhine Medical Company Information
13.8.2 Lanhine Medical Bio-based Hemostatic Powder Product Portfolios and Specifications
13.8.3 Lanhine Medical Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Lanhine Medical Main Business Overview
13.8.5 Lanhine Medical Latest Developments
13.9 Haiyuan Hairun
13.9.1 Haiyuan Hairun Company Information
13.9.2 Haiyuan Hairun Bio-based Hemostatic Powder Product Portfolios and Specifications
13.9.3 Haiyuan Hairun Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Haiyuan Hairun Main Business Overview
13.9.5 Haiyuan Hairun Latest Developments
13.10 Yancheng Yankang Medical Equipment
13.10.1 Yancheng Yankang Medical Equipment Company Information
13.10.2 Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Product Portfolios and Specifications
13.10.3 Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Yancheng Yankang Medical Equipment Main Business Overview
13.10.5 Yancheng Yankang Medical Equipment Latest Developments
13.11 Success Bio-Tech
13.11.1 Success Bio-Tech Company Information
13.11.2 Success Bio-Tech Bio-based Hemostatic Powder Product Portfolios and Specifications
13.11.3 Success Bio-Tech Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Success Bio-Tech Main Business Overview
13.11.5 Success Bio-Tech Latest Developments
13.12 Beijing Aitekang Medical Technology
13.12.1 Beijing Aitekang Medical Technology Company Information
13.12.2 Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Product Portfolios and Specifications
13.12.3 Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Beijing Aitekang Medical Technology Main Business Overview
13.12.5 Beijing Aitekang Medical Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Bio-based Hemostatic Powder Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Bio-based Hemostatic Powder Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oxidized Cellulose
Table 4. Major Players of Polysaccharides
Table 5. Major Players of Other
Table 6. Global Bio-based Hemostatic Powder Sales by Type (2021-2026) & (Units)
Table 7. Global Bio-based Hemostatic Powder Sales Market Share by Type (2021-2026)
Table 8. Global Bio-based Hemostatic Powder Revenue by Type (2021-2026) & ($ million)
Table 9. Global Bio-based Hemostatic Powder Revenue Market Share by Type (2021-2026)
Table 10. Global Bio-based Hemostatic Powder Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Bio-based Hemostatic Powder Sale by Application (2021-2026) & (Units)
Table 12. Global Bio-based Hemostatic Powder Sale Market Share by Application (2021-2026)
Table 13. Global Bio-based Hemostatic Powder Revenue by Application (2021-2026) & ($ million)
Table 14. Global Bio-based Hemostatic Powder Revenue Market Share by Application (2021-2026)
Table 15. Global Bio-based Hemostatic Powder Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Bio-based Hemostatic Powder Sales by Company (2021-2026) & (Units)
Table 17. Global Bio-based Hemostatic Powder Sales Market Share by Company (2021-2026)
Table 18. Global Bio-based Hemostatic Powder Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Bio-based Hemostatic Powder Revenue Market Share by Company (2021-2026)
Table 20. Global Bio-based Hemostatic Powder Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Bio-based Hemostatic Powder Producing Area Distribution and Sales Area
Table 22. Players Bio-based Hemostatic Powder Products Offered
Table 23. Bio-based Hemostatic Powder Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Bio-based Hemostatic Powder Sales by Geographic Region (2021-2026) & (Units)
Table 27. Global Bio-based Hemostatic Powder Sales Market Share Geographic Region (2021-2026)
Table 28. Global Bio-based Hemostatic Powder Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Bio-based Hemostatic Powder Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Bio-based Hemostatic Powder Sales by Country/Region (2021-2026) & (Units)
Table 31. Global Bio-based Hemostatic Powder Sales Market Share by Country/Region (2021-2026)
Table 32. Global Bio-based Hemostatic Powder Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Bio-based Hemostatic Powder Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Bio-based Hemostatic Powder Sales by Country (2021-2026) & (Units)
Table 35. Americas Bio-based Hemostatic Powder Sales Market Share by Country (2021-2026)
Table 36. Americas Bio-based Hemostatic Powder Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Bio-based Hemostatic Powder Sales by Type (2021-2026) & (Units)
Table 38. Americas Bio-based Hemostatic Powder Sales by Application (2021-2026) & (Units)
Table 39. APAC Bio-based Hemostatic Powder Sales by Region (2021-2026) & (Units)
Table 40. APAC Bio-based Hemostatic Powder Sales Market Share by Region (2021-2026)
Table 41. APAC Bio-based Hemostatic Powder Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Bio-based Hemostatic Powder Sales by Type (2021-2026) & (Units)
Table 43. APAC Bio-based Hemostatic Powder Sales by Application (2021-2026) & (Units)
Table 44. Europe Bio-based Hemostatic Powder Sales by Country (2021-2026) & (Units)
Table 45. Europe Bio-based Hemostatic Powder Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Bio-based Hemostatic Powder Sales by Type (2021-2026) & (Units)
Table 47. Europe Bio-based Hemostatic Powder Sales by Application (2021-2026) & (Units)
Table 48. Middle East & Africa Bio-based Hemostatic Powder Sales by Country (2021-2026) & (Units)
Table 49. Middle East & Africa Bio-based Hemostatic Powder Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Bio-based Hemostatic Powder Sales by Type (2021-2026) & (Units)
Table 51. Middle East & Africa Bio-based Hemostatic Powder Sales by Application (2021-2026) & (Units)
Table 52. Key Market Drivers & Growth Opportunities of Bio-based Hemostatic Powder
Table 53. Key Market Challenges & Risks of Bio-based Hemostatic Powder
Table 54. Key Industry Trends of Bio-based Hemostatic Powder
Table 55. Bio-based Hemostatic Powder Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Bio-based Hemostatic Powder Distributors List
Table 58. Bio-based Hemostatic Powder Customer List
Table 59. Global Bio-based Hemostatic Powder Sales Forecast by Region (2027-2032) & (Units)
Table 60. Global Bio-based Hemostatic Powder Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Bio-based Hemostatic Powder Sales Forecast by Country (2027-2032) & (Units)
Table 62. Americas Bio-based Hemostatic Powder Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Bio-based Hemostatic Powder Sales Forecast by Region (2027-2032) & (Units)
Table 64. APAC Bio-based Hemostatic Powder Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Bio-based Hemostatic Powder Sales Forecast by Country (2027-2032) & (Units)
Table 66. Europe Bio-based Hemostatic Powder Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Bio-based Hemostatic Powder Sales Forecast by Country (2027-2032) & (Units)
Table 68. Middle East & Africa Bio-based Hemostatic Powder Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Bio-based Hemostatic Powder Sales Forecast by Type (2027-2032) & (Units)
Table 70. Global Bio-based Hemostatic Powder Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Bio-based Hemostatic Powder Sales Forecast by Application (2027-2032) & (Units)
Table 72. Global Bio-based Hemostatic Powder Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Johnson & Johnson Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 74. Johnson & Johnson Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 75. Johnson & Johnson Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Johnson & Johnson Main Business
Table 77. Johnson & Johnson Latest Developments
Table 78. Medtronic Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 79. Medtronic Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 80. Medtronic Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Medtronic Main Business
Table 82. Medtronic Latest Developments
Table 83. Baxter Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 84. Baxter Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 85. Baxter Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Baxter Main Business
Table 87. Baxter Latest Developments
Table 88. BioCer Entwicklungs-GmbH Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 89. BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 90. BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. BioCer Entwicklungs-GmbH Main Business
Table 92. BioCer Entwicklungs-GmbH Latest Developments
Table 93. BD Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 94. BD Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 95. BD Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. BD Main Business
Table 97. BD Latest Developments
Table 98. Hemostasis Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 99. Hemostasis Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 100. Hemostasis Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Hemostasis Main Business
Table 102. Hemostasis Latest Developments
Table 103. MedTrade Products Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 104. MedTrade Products Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 105. MedTrade Products Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. MedTrade Products Main Business
Table 107. MedTrade Products Latest Developments
Table 108. Lanhine Medical Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 109. Lanhine Medical Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 110. Lanhine Medical Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Lanhine Medical Main Business
Table 112. Lanhine Medical Latest Developments
Table 113. Haiyuan Hairun Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 114. Haiyuan Hairun Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 115. Haiyuan Hairun Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Haiyuan Hairun Main Business
Table 117. Haiyuan Hairun Latest Developments
Table 118. Yancheng Yankang Medical Equipment Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 119. Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 120. Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Yancheng Yankang Medical Equipment Main Business
Table 122. Yancheng Yankang Medical Equipment Latest Developments
Table 123. Success Bio-Tech Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 124. Success Bio-Tech Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 125. Success Bio-Tech Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Success Bio-Tech Main Business
Table 127. Success Bio-Tech Latest Developments
Table 128. Beijing Aitekang Medical Technology Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 129. Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 130. Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Beijing Aitekang Medical Technology Main Business
Table 132. Beijing Aitekang Medical Technology Latest Developments
Table 1. Bio-based Hemostatic Powder Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Bio-based Hemostatic Powder Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oxidized Cellulose
Table 4. Major Players of Polysaccharides
Table 5. Major Players of Other
Table 6. Global Bio-based Hemostatic Powder Sales by Type (2021-2026) & (Units)
Table 7. Global Bio-based Hemostatic Powder Sales Market Share by Type (2021-2026)
Table 8. Global Bio-based Hemostatic Powder Revenue by Type (2021-2026) & ($ million)
Table 9. Global Bio-based Hemostatic Powder Revenue Market Share by Type (2021-2026)
Table 10. Global Bio-based Hemostatic Powder Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Bio-based Hemostatic Powder Sale by Application (2021-2026) & (Units)
Table 12. Global Bio-based Hemostatic Powder Sale Market Share by Application (2021-2026)
Table 13. Global Bio-based Hemostatic Powder Revenue by Application (2021-2026) & ($ million)
Table 14. Global Bio-based Hemostatic Powder Revenue Market Share by Application (2021-2026)
Table 15. Global Bio-based Hemostatic Powder Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Bio-based Hemostatic Powder Sales by Company (2021-2026) & (Units)
Table 17. Global Bio-based Hemostatic Powder Sales Market Share by Company (2021-2026)
Table 18. Global Bio-based Hemostatic Powder Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Bio-based Hemostatic Powder Revenue Market Share by Company (2021-2026)
Table 20. Global Bio-based Hemostatic Powder Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Bio-based Hemostatic Powder Producing Area Distribution and Sales Area
Table 22. Players Bio-based Hemostatic Powder Products Offered
Table 23. Bio-based Hemostatic Powder Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Bio-based Hemostatic Powder Sales by Geographic Region (2021-2026) & (Units)
Table 27. Global Bio-based Hemostatic Powder Sales Market Share Geographic Region (2021-2026)
Table 28. Global Bio-based Hemostatic Powder Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Bio-based Hemostatic Powder Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Bio-based Hemostatic Powder Sales by Country/Region (2021-2026) & (Units)
Table 31. Global Bio-based Hemostatic Powder Sales Market Share by Country/Region (2021-2026)
Table 32. Global Bio-based Hemostatic Powder Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Bio-based Hemostatic Powder Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Bio-based Hemostatic Powder Sales by Country (2021-2026) & (Units)
Table 35. Americas Bio-based Hemostatic Powder Sales Market Share by Country (2021-2026)
Table 36. Americas Bio-based Hemostatic Powder Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Bio-based Hemostatic Powder Sales by Type (2021-2026) & (Units)
Table 38. Americas Bio-based Hemostatic Powder Sales by Application (2021-2026) & (Units)
Table 39. APAC Bio-based Hemostatic Powder Sales by Region (2021-2026) & (Units)
Table 40. APAC Bio-based Hemostatic Powder Sales Market Share by Region (2021-2026)
Table 41. APAC Bio-based Hemostatic Powder Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Bio-based Hemostatic Powder Sales by Type (2021-2026) & (Units)
Table 43. APAC Bio-based Hemostatic Powder Sales by Application (2021-2026) & (Units)
Table 44. Europe Bio-based Hemostatic Powder Sales by Country (2021-2026) & (Units)
Table 45. Europe Bio-based Hemostatic Powder Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Bio-based Hemostatic Powder Sales by Type (2021-2026) & (Units)
Table 47. Europe Bio-based Hemostatic Powder Sales by Application (2021-2026) & (Units)
Table 48. Middle East & Africa Bio-based Hemostatic Powder Sales by Country (2021-2026) & (Units)
Table 49. Middle East & Africa Bio-based Hemostatic Powder Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Bio-based Hemostatic Powder Sales by Type (2021-2026) & (Units)
Table 51. Middle East & Africa Bio-based Hemostatic Powder Sales by Application (2021-2026) & (Units)
Table 52. Key Market Drivers & Growth Opportunities of Bio-based Hemostatic Powder
Table 53. Key Market Challenges & Risks of Bio-based Hemostatic Powder
Table 54. Key Industry Trends of Bio-based Hemostatic Powder
Table 55. Bio-based Hemostatic Powder Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Bio-based Hemostatic Powder Distributors List
Table 58. Bio-based Hemostatic Powder Customer List
Table 59. Global Bio-based Hemostatic Powder Sales Forecast by Region (2027-2032) & (Units)
Table 60. Global Bio-based Hemostatic Powder Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Bio-based Hemostatic Powder Sales Forecast by Country (2027-2032) & (Units)
Table 62. Americas Bio-based Hemostatic Powder Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Bio-based Hemostatic Powder Sales Forecast by Region (2027-2032) & (Units)
Table 64. APAC Bio-based Hemostatic Powder Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Bio-based Hemostatic Powder Sales Forecast by Country (2027-2032) & (Units)
Table 66. Europe Bio-based Hemostatic Powder Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Bio-based Hemostatic Powder Sales Forecast by Country (2027-2032) & (Units)
Table 68. Middle East & Africa Bio-based Hemostatic Powder Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Bio-based Hemostatic Powder Sales Forecast by Type (2027-2032) & (Units)
Table 70. Global Bio-based Hemostatic Powder Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Bio-based Hemostatic Powder Sales Forecast by Application (2027-2032) & (Units)
Table 72. Global Bio-based Hemostatic Powder Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Johnson & Johnson Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 74. Johnson & Johnson Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 75. Johnson & Johnson Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Johnson & Johnson Main Business
Table 77. Johnson & Johnson Latest Developments
Table 78. Medtronic Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 79. Medtronic Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 80. Medtronic Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Medtronic Main Business
Table 82. Medtronic Latest Developments
Table 83. Baxter Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 84. Baxter Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 85. Baxter Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Baxter Main Business
Table 87. Baxter Latest Developments
Table 88. BioCer Entwicklungs-GmbH Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 89. BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 90. BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. BioCer Entwicklungs-GmbH Main Business
Table 92. BioCer Entwicklungs-GmbH Latest Developments
Table 93. BD Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 94. BD Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 95. BD Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. BD Main Business
Table 97. BD Latest Developments
Table 98. Hemostasis Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 99. Hemostasis Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 100. Hemostasis Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Hemostasis Main Business
Table 102. Hemostasis Latest Developments
Table 103. MedTrade Products Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 104. MedTrade Products Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 105. MedTrade Products Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. MedTrade Products Main Business
Table 107. MedTrade Products Latest Developments
Table 108. Lanhine Medical Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 109. Lanhine Medical Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 110. Lanhine Medical Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Lanhine Medical Main Business
Table 112. Lanhine Medical Latest Developments
Table 113. Haiyuan Hairun Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 114. Haiyuan Hairun Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 115. Haiyuan Hairun Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Haiyuan Hairun Main Business
Table 117. Haiyuan Hairun Latest Developments
Table 118. Yancheng Yankang Medical Equipment Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 119. Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 120. Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Yancheng Yankang Medical Equipment Main Business
Table 122. Yancheng Yankang Medical Equipment Latest Developments
Table 123. Success Bio-Tech Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 124. Success Bio-Tech Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 125. Success Bio-Tech Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Success Bio-Tech Main Business
Table 127. Success Bio-Tech Latest Developments
Table 128. Beijing Aitekang Medical Technology Basic Information, Bio-based Hemostatic Powder Manufacturing Base, Sales Area and Its Competitors
Table 129. Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Product Portfolios and Specifications
Table 130. Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Beijing Aitekang Medical Technology Main Business
Table 132. Beijing Aitekang Medical Technology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Bio-based Hemostatic Powder
Figure 2. Bio-based Hemostatic Powder Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bio-based Hemostatic Powder Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Bio-based Hemostatic Powder Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Bio-based Hemostatic Powder Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Bio-based Hemostatic Powder Sales Market Share by Country/Region (2025)
Figure 10. Bio-based Hemostatic Powder Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Oxidized Cellulose
Figure 12. Product Picture of Polysaccharides
Figure 13. Product Picture of Other
Figure 14. Global Bio-based Hemostatic Powder Sales Market Share by Type in 2026
Figure 15. Global Bio-based Hemostatic Powder Revenue Market Share by Type (2021-2026)
Figure 16. Bio-based Hemostatic Powder Consumed in Surgery
Figure 17. Global Bio-based Hemostatic Powder Market: Surgery (2021-2026) & (Units)
Figure 18. Bio-based Hemostatic Powder Consumed in First Aid
Figure 19. Global Bio-based Hemostatic Powder Market: First Aid (2021-2026) & (Units)
Figure 20. Global Bio-based Hemostatic Powder Sale Market Share by Application (2025)
Figure 21. Global Bio-based Hemostatic Powder Revenue Market Share by Application in 2026
Figure 22. Bio-based Hemostatic Powder Sales by Company in 2026 (Units)
Figure 23. Global Bio-based Hemostatic Powder Sales Market Share by Company in 2026
Figure 24. Bio-based Hemostatic Powder Revenue by Company in 2026 ($ millions)
Figure 25. Global Bio-based Hemostatic Powder Revenue Market Share by Company in 2026
Figure 26. Global Bio-based Hemostatic Powder Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Bio-based Hemostatic Powder Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Bio-based Hemostatic Powder Sales 2021-2026 (Units)
Figure 29. Americas Bio-based Hemostatic Powder Revenue 2021-2026 ($ millions)
Figure 30. APAC Bio-based Hemostatic Powder Sales 2021-2026 (Units)
Figure 31. APAC Bio-based Hemostatic Powder Revenue 2021-2026 ($ millions)
Figure 32. Europe Bio-based Hemostatic Powder Sales 2021-2026 (Units)
Figure 33. Europe Bio-based Hemostatic Powder Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Bio-based Hemostatic Powder Sales 2021-2026 (Units)
Figure 35. Middle East & Africa Bio-based Hemostatic Powder Revenue 2021-2026 ($ millions)
Figure 36. Americas Bio-based Hemostatic Powder Sales Market Share by Country in 2026
Figure 37. Americas Bio-based Hemostatic Powder Revenue Market Share by Country (2021-2026)
Figure 38. Americas Bio-based Hemostatic Powder Sales Market Share by Type (2021-2026)
Figure 39. Americas Bio-based Hemostatic Powder Sales Market Share by Application (2021-2026)
Figure 40. United States Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Bio-based Hemostatic Powder Sales Market Share by Region in 2026
Figure 45. APAC Bio-based Hemostatic Powder Revenue Market Share by Region (2021-2026)
Figure 46. APAC Bio-based Hemostatic Powder Sales Market Share by Type (2021-2026)
Figure 47. APAC Bio-based Hemostatic Powder Sales Market Share by Application (2021-2026)
Figure 48. China Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 52. India Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Bio-based Hemostatic Powder Sales Market Share by Country in 2026
Figure 56. Europe Bio-based Hemostatic Powder Revenue Market Share by Country (2021-2026)
Figure 57. Europe Bio-based Hemostatic Powder Sales Market Share by Type (2021-2026)
Figure 58. Europe Bio-based Hemostatic Powder Sales Market Share by Application (2021-2026)
Figure 59. Germany Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 60. France Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Bio-based Hemostatic Powder Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Bio-based Hemostatic Powder Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Bio-based Hemostatic Powder Sales Market Share by Application (2021-2026)
Figure 67. Egypt Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Bio-based Hemostatic Powder in 2026
Figure 73. Manufacturing Process Analysis of Bio-based Hemostatic Powder
Figure 74. Industry Chain Structure of Bio-based Hemostatic Powder
Figure 75. Channels of Distribution
Figure 76. Global Bio-based Hemostatic Powder Sales Market Forecast by Region (2027-2032)
Figure 77. Global Bio-based Hemostatic Powder Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Bio-based Hemostatic Powder Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Bio-based Hemostatic Powder Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Bio-based Hemostatic Powder Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Bio-based Hemostatic Powder Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Bio-based Hemostatic Powder
Figure 2. Bio-based Hemostatic Powder Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bio-based Hemostatic Powder Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Bio-based Hemostatic Powder Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Bio-based Hemostatic Powder Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Bio-based Hemostatic Powder Sales Market Share by Country/Region (2025)
Figure 10. Bio-based Hemostatic Powder Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Oxidized Cellulose
Figure 12. Product Picture of Polysaccharides
Figure 13. Product Picture of Other
Figure 14. Global Bio-based Hemostatic Powder Sales Market Share by Type in 2026
Figure 15. Global Bio-based Hemostatic Powder Revenue Market Share by Type (2021-2026)
Figure 16. Bio-based Hemostatic Powder Consumed in Surgery
Figure 17. Global Bio-based Hemostatic Powder Market: Surgery (2021-2026) & (Units)
Figure 18. Bio-based Hemostatic Powder Consumed in First Aid
Figure 19. Global Bio-based Hemostatic Powder Market: First Aid (2021-2026) & (Units)
Figure 20. Global Bio-based Hemostatic Powder Sale Market Share by Application (2025)
Figure 21. Global Bio-based Hemostatic Powder Revenue Market Share by Application in 2026
Figure 22. Bio-based Hemostatic Powder Sales by Company in 2026 (Units)
Figure 23. Global Bio-based Hemostatic Powder Sales Market Share by Company in 2026
Figure 24. Bio-based Hemostatic Powder Revenue by Company in 2026 ($ millions)
Figure 25. Global Bio-based Hemostatic Powder Revenue Market Share by Company in 2026
Figure 26. Global Bio-based Hemostatic Powder Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Bio-based Hemostatic Powder Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Bio-based Hemostatic Powder Sales 2021-2026 (Units)
Figure 29. Americas Bio-based Hemostatic Powder Revenue 2021-2026 ($ millions)
Figure 30. APAC Bio-based Hemostatic Powder Sales 2021-2026 (Units)
Figure 31. APAC Bio-based Hemostatic Powder Revenue 2021-2026 ($ millions)
Figure 32. Europe Bio-based Hemostatic Powder Sales 2021-2026 (Units)
Figure 33. Europe Bio-based Hemostatic Powder Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Bio-based Hemostatic Powder Sales 2021-2026 (Units)
Figure 35. Middle East & Africa Bio-based Hemostatic Powder Revenue 2021-2026 ($ millions)
Figure 36. Americas Bio-based Hemostatic Powder Sales Market Share by Country in 2026
Figure 37. Americas Bio-based Hemostatic Powder Revenue Market Share by Country (2021-2026)
Figure 38. Americas Bio-based Hemostatic Powder Sales Market Share by Type (2021-2026)
Figure 39. Americas Bio-based Hemostatic Powder Sales Market Share by Application (2021-2026)
Figure 40. United States Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Bio-based Hemostatic Powder Sales Market Share by Region in 2026
Figure 45. APAC Bio-based Hemostatic Powder Revenue Market Share by Region (2021-2026)
Figure 46. APAC Bio-based Hemostatic Powder Sales Market Share by Type (2021-2026)
Figure 47. APAC Bio-based Hemostatic Powder Sales Market Share by Application (2021-2026)
Figure 48. China Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 52. India Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Bio-based Hemostatic Powder Sales Market Share by Country in 2026
Figure 56. Europe Bio-based Hemostatic Powder Revenue Market Share by Country (2021-2026)
Figure 57. Europe Bio-based Hemostatic Powder Sales Market Share by Type (2021-2026)
Figure 58. Europe Bio-based Hemostatic Powder Sales Market Share by Application (2021-2026)
Figure 59. Germany Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 60. France Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Bio-based Hemostatic Powder Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Bio-based Hemostatic Powder Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Bio-based Hemostatic Powder Sales Market Share by Application (2021-2026)
Figure 67. Egypt Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Bio-based Hemostatic Powder Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Bio-based Hemostatic Powder in 2026
Figure 73. Manufacturing Process Analysis of Bio-based Hemostatic Powder
Figure 74. Industry Chain Structure of Bio-based Hemostatic Powder
Figure 75. Channels of Distribution
Figure 76. Global Bio-based Hemostatic Powder Sales Market Forecast by Region (2027-2032)
Figure 77. Global Bio-based Hemostatic Powder Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Bio-based Hemostatic Powder Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Bio-based Hemostatic Powder Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Bio-based Hemostatic Powder Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Bio-based Hemostatic Powder Revenue Market Share Forecast by Application (2027-2032)
